The Association between ER, PR, HER2, and ER−/PR+ Expression and Lung Cancer Subsequent in Breast Cancer Patients: A Retrospective Cohort Study Based on SEER Database
Aims. The available research on the association between estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2), ER−/PR+ status, and the occurrence of lung cancer subsequent to breast cancer in patients (referred to as BC-LuC) had been limited. Consequentl...
Saved in:
Main Authors: | Hong Yu Shao, Bao Tan Hao, Feng Xiao Gao |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-01-01
|
Series: | The Breast Journal |
Online Access: | http://dx.doi.org/10.1155/2023/7028189 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Looking beyond the ER, PR, and HER2: what’s new in the ARsenal for combating breast cancer?
by: Tryambak Pratap Srivastava, et al.
Published: (2025-01-01) -
An assessment of breast cancer HER2, ER, and PR expressions based on mammography using deep learning with convolutional neural networks
by: Shun Zeng, et al.
Published: (2025-02-01) -
Stromal Expression of CD10 in Invasive Breast Carcinoma and Its Correlation with ER, PR, HER2-neu, and Ki67
by: Vandana Puri, et al.
Published: (2011-01-01) -
Early Delivery of Misfolded PrP from ER to Lysosomes by Autophagy
by: Constanza J. Cortes, et al.
Published: (2013-01-01) -
Phase I trial of hydroxychloroquine to enhance palbociclib and letrozole efficacy in ER+/HER2− breast cancer
by: Akshara Singareeka Raghavendra, et al.
Published: (2025-01-01)